Brief: Active Biotech Q1 Loss Widens To SEK 15.7 Million

Active Biotech AB publ

21/04/2022 07:33

April 21 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * REG-ACTIVE BIOTECH INTERIM REPORT Q1 2022
    * Q1 OPERATING LOSS SEK 15,3 MILLION VERSUS LOSS SEK SEK 9.7
MILLION YEAR AGO
    * Q1 LOSS AFTER TAX SEK 15,7 MILLION VERSUS VERSUS LOSS SEK
9,8
MILLION YEAR AGO

Source text for Eikon:  ID:nGNE86bfwC 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))